To evaluate the effectiveness of allogeneic stem cell transplantation as a treatment for T-cell prolymphocytic leukemia and its potential for curing this disease.
Analysis of outcomes following allogeneic stem cell transplantation in patients with T-cell prolymphocytic leukemia.
Assessment of graft-versus-leukemia effects and survival rates.
Some patients achieved remission, but overall survival rates were low.
Complications and disease relapse were common, indicating challenges in achieving a lasting cure.